Efficient suppression of NRAS-driven melanoma by co-inhibition of ERK1/2 and ERK5 MAPK pathways. Adam C, Fusi L, Weiss N, Goller SG, Meder K, Frings VG, Kneitz H, Goebeler M, Houben R, Schrama D, Schmidt M. J Invest Dermatol. 2020 May 3. pii: S0022-202X(20)31407-X. doi: 10.1016/j.jid.2020.03.972. [Epub ahead of print]
|